Innovation of novel therapeutic approach to pancreatic cancer using galectin-3 and AMF
Project/Area Number |
23592017
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Fukushima Medical University |
Principal Investigator |
SHIMURA Tatsuo 福島県立医科大学, 医学部, 准教授 (00282393)
|
Co-Investigator(Kenkyū-buntansha) |
SHIBATA Masahiko 福島県立医科大学, 医学部, 教授 (10226178)
TAKENOSHITA Seiichi 福島県立医科大学, 医学部, 教授 (10167489)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2011: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Keywords | galectin-3 / 膵癌 / AMF / AMF / IPMC / galectin |
Research Abstract |
Galectin-3 (Gal-3) is beta-galactoside-binding protein, having binding capacity with glycoprotein and glycolipid on a cell surface. Gal-3 engages in cell differentiation, organ formation, tumor progression, apoptosis and so on, however, precise mechanisms of them have not yet been clarified. We investigated the relationship between Gal-3 and pancreatic cancer, especially on cell proliferation, migration and invasion using pancreatic cancer cell lines. We also analyzed changes of tolerance toward anti-cancer drugs when expression level of Gal-3 was inhibited in the cell lines. Inhibition of Gal-3 expression led to inhibition of migration and invasion of the cells. It also augmented their susceptibility to anti-cancer agents, like gemcitabine and cisplatinum.
|
Report
(4 results)
Research Products
(32 results)
-
[Journal Article] Serum levels of vascular endothelial growth factor are increased and correlate with malnutrition, immunosuppression invoving MDSCs and systemic inflammation in patients with cancer of the digestive system2013
Author(s)
Nakamura I, Shibata M, Gonda K, Yazawa T, Shimura T, Anazawa T, Suzuki S, Sakurai K, Koyama Y, Ohto H, Tomita R, Gotoh M, Takenoshita S.
-
Journal Title
Oncology Letters
Volume: 5巻
Pages: 1682-1688
URL
Related Report
Peer Reviewed
-
[Journal Article] Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers2013
Author(s)
Yazawa T, Shibata M, Gonda K, Machida T, Suzuki S, Kenjo A, Nakamura I, Tsuchiya T, Koyama Y, Sakurai K, Shimura T, Tomita R, Ohto H, Gotoh M, Takenoshita S.
-
Journal Title
Mol Clin Oncol
Volume: 1巻
Pages: 675-679
URL
Related Report
Peer Reviewed
-
-
[Journal Article] 1. Serum levels of vascular endothelial growth factor are increased and correlate with malnutrition, immunosuppression involving MDSCs and systemic inflammation in patients with cancer of the digestive system.2013
Author(s)
Nakamura I, Shibata M, Gonda K, Yazawa T, Shimura T, Anazawa T, Suzuki S, Sakurai K, Koyama Y, Ohto H, Tomita R, Gotoh M, Takenoshita S.
-
Journal Title
Oncology Letters
Volume: 5(5)
Pages: 1682-1688
Related Report
Peer Reviewed
-
[Journal Article] Increased IL-17 production correlates with immunosuppression involving myeloid-derived suppressor cells and nutritional impairment in patients with various gastrointestinal cancers.2013
Author(s)
Yazawa T, Shibata M, Gonda K, Machida T, Suzuki S, Kenjo A, Nakamura I, Tsuchiya T, Koyama Y, Sakurai K, Shimura T, Tomita R, Ohto H, Gotoh M, Takenoshita S.
-
Journal Title
Mol Clin Oncol.
Volume: 1(4)
Pages: 675-679
Related Report
Peer Reviewed
-
-
[Journal Article] Circulating myeloid-derived suppressor cells are increased and correlate to immune suppression, inflammation and hypoproteinemia in patients with cancer.2012
Author(s)
Ohki S, Shibata M, Gonda K, Machida T, Shimura T, Nakamura I, Ohtake T, Koyama Y, Suzuki S, Ohto H, Takenoshita S.
-
Journal Title
Oncology Report
Volume: 28
Issue: 2
Pages: 453-458
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Clinical evaluation of dedritic cells vaccination for advanced cancer patients at Fukushima Medical University2012
Author(s)
Nakamura I, Kanazawa M, Sato Y, Irisawa A, Takagi T, Ogata T, Kashimura S, Kenjo A, Suzuki H, Shibata M, Shimura T, Ohira H, Goto M, Takenoshita S, Ohto H.
-
Journal Title
Fukushima J Med Sci.
Volume: 58巻
Pages: 40-48
URL
Related Report
Peer Reviewed
-
-
[Journal Article] Clinical evaluation of dendritic cells vaccination for advanced cancer patients at Fukushima Medical University.2012
Author(s)
Nakamura I, Kanazawa M, Sato Y, Irisawa A, Takagi T, Ogata T, Kashimura S, Kenjo A, Suzuki H, Shibata M, Shimura T, Ohira H, Goto M, Takenoshita S, Ohto H.
-
Journal Title
Fukushima J Med Sci.
Volume: 58
Pages: 40-48
NAID
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
[Presentation] Circulating myeloid-derived suppressor cells (MDSC) and correlation to poor prognosis, Th2 polarization, and nutritional damages in patients with gastric cancer.2013
Author(s)
Gonda K, Shibata M, Kanke T, Yazawa T, Monma T, Suzuki S, Nakamurea S, Ohki S, Shimura T, Ohto H, Takenoshita S.
Organizer
49th Annual Meeting, ASCO
Place of Presentation
シカゴ
Related Report
-
-
-
[Presentation] Myeloid–Derived Suppressor Cells (MDSC) is increased and correlated to immune suppression, nutritional impairment and inflammatory markers in patients with gastrointestinal cancer.2012
Author(s)
Shibata, M., Shimura, T., Gonda, K., Suzuki, S., Nakamura, I., Ohki, S, Takenoshita, S.
Organizer
2012 ASCO Gastrointestinal Cancer Symposium
Place of Presentation
San Francisco
Related Report
-
-
-
-
-
-
-
-